Ranjit R. Deshmukh, PhD is currently Senior Director/ Head, Corporate Manufacturing Science and Technology in the Global Technical Operations group at MedImmune, a division of AstraZeneca. He has over eighteen years experience in the pharmaceutical industry in process development, technology transfer, validation and product commercialization for vaccines and biological products. Prior to current position he was at Wyeth and Pfizer. He Co-Chairs the QbD Steering team in his current company and was part of the A-Vax Case Study team. Within ISPE he chairs the PQLI Biotech team and is a member of the Biotech COP steering team and PQLI Technical Committee. He received his B.Tech ChemE degree from Indian Institute of Technology, Varanasi, M.S. ChemE from the University of Kentucky and Ph.D. ChemE from the University of Arizona.